OneMedNet Corporation filed a Form 8-K on September 23, 2026, reporting the outcomes of its 2026 Annual Meeting of Stockholders held virtually on September 18, 2026, including approval of an expanded equity incentive plan and authorization for a potential reverse stock split.

Key Highlights

  • Quorum reached: 41,841,452 votes were represented at the Annual Meeting, equal to 70.57% of votes entitled to be cast.
  • Three directors elected: Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu were elected as Class III directors to serve three-year terms expiring at the 2029 Annual Meeting.
  • Equity plan expanded: Stockholders approved an amendment to the 2022 Equity Incentive Plan increasing the authorized share reserve by 1,000,000 shares, effective immediately upon approval.
  • Auditor ratified: WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for the year ending December 31, 2026, with 41,660,426 votes in favor.
  • Reverse split authorized: Stockholders approved an amendment to the certificate of incorporation allowing a reverse stock split at a ratio of between 1-for-5 and 1-for-20, as determined by the Board of Directors in its discretion, with 41,068,200 votes in favor.

OneMedNet 2026 Annual Meeting: Director Elections, Equity Plan, and Reverse Split Authorization

OneMedNet Corporation (NASDAQ:ONMDW), a Delaware-incorporated company headquartered in Eden Prairie, Minnesota, disclosed the results of its 2026 Annual Meeting of Stockholders via a current report filed with the SEC. The meeting was conducted as a virtual event via live audio webcast on September 18, 2026. According to the filing, stockholders considered and acted on four separate proposals.

On Proposal 1, all three Class III director nominees were elected. Dr. Kenneth Alleyne received 36,342,215 votes for and 150,268 withheld; Sherry Coonse McCraw received 36,343,428 votes for and 149,055 withheld; and Dr. Jeffrey Yu received 36,308,073 votes for and 184,410 withheld. Each director is set to serve until the 2029 Annual Meeting of Stockholders. Broker non-votes for this proposal totaled 5,348,969. On Proposal 2, the ratification of WithumSmith+Brown, PC drew 41,660,426 votes in favor, 138,717 against, and 42,309 abstentions, with no broker non-votes recorded.

Regarding the equity incentive plan, the filing disclosed that the OneMedNet Corporation Amended and Restated 2022 Equity Incentive Plan was approved by stockholders with 34,528,269 votes for, 1,868,479 against, and 95,735 abstentions, alongside 5,348,969 broker non-votes. The plan became effective immediately upon stockholder approval, according to the filing. The filing noted that a summary of the plan's material terms appeared in the company's definitive proxy statement filed with the SEC on August 19, 2026. On Proposal 4, stockholders approved the potential reverse stock split amendment with 41,068,200 votes for, 739,329 against, and 33,923 abstentions; the specific ratio within the approved 1-for-5 to 1-for-20 range would be determined by the Board of Directors in its discretion.

What Was Disclosed

The filing reported the voting results from OneMedNet's September 18, 2026 Annual Meeting, covering director elections, auditor ratification, an equity plan share increase of 1,000,000 shares, and stockholder authorization of a potential reverse stock split at a board-determined ratio.